News
cataract surgery
OCS-01 eye drops receive positive Phase 3 trial results
Results from the Phase 3 OPTIMIZE-1 trial of OCS-01, a once-daily, preservative-free corticosteroid eye drop, were presented at the 2024 ASCRS Annual Meeting.
eye drops
FDA warns consumers regarding copycat Lumify eyedrops
While no adverse events have been reported for any of the copycat products, the agency has received complaints of quality concerns, eye irritation, pain and infection.
eye drops
FDA urges Congress to take steps to improve safety of over-the-counter eye drops
Congress is being called upon by the Food and Drug Administration to bestow new powers upon the agency to mandate recalls and force eyedrop manufacturers to be subjected to inspections prior to th...
eye drops
More eye drops recalled by the FDA
The eye drops market has been hit yet again with potentially contaminated eye drops that can cause serious eye infections or even blindness.
eye drops
Contaminated eye drops continue to be a problem
Since the beginning of 2023, several eye drops and lubricants have been recalled by the Food and Drug Administration.
dry eye
FDA issues safety alert regarding amniotic fluid eye drops
The Food and Drug Administration (FDA) has sent letters to two manufacturers regarding their unlawful marketing of amniotic fluid eyedrops.
eye drops
New treatments for presbyopia are being developed
Topical, non-invasive treatments may soon be available to people over the age of 40 who need reading glasses.